AN2 Therapeutics, Inc.'s total assets for Q1 2025 were $81.34M, a decrease of -11.67% from the previous quarter. ANTX total liabilities were $8.01M for the fiscal quarter, a -21.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.